Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

The State of Texas has awarded a contract to Merck Sharp & Dohme Corp. (Prime Contractor) effective June 23, 2026, for the procurement of childhood vaccines priced in accordance with the Centers for Disease Control and Prevention (CDC) Federal Contract for Vaccine and Biologicals (CDC Federal Contract Number: 75D30126D20729). The procurement was authorized under Texas Government Code Section 2155.144 for goods and services acquired for the benefit of clients enrolled in programs operated by the agency, with governance under Texas Government Code Section 771. The contract, identified as HHSTX-6-0000407475, encompasses immunization products classified under the National Institute of Governmental Purchasing (NIGP) category "Serums, Toxoids, and Vaccines."

The specific vaccine products covered under this contract include diphtheria, tetanus, and whole-cell pertussis vaccine formulations. Pricing is established by direct reference to the existing CDC Federal Contract, ensuring alignment with federal acquisition standards and established vaccine pricing structures. While specific annual values, cumulative contract values, and periods of performance are not detailed in the contract documentation provided, the contract establishes Merck Sharp & Dohme Corp. as the authorized supplier for these pharmaceutical biologicals to Texas state health programs and their beneficiaries.